Virginia bill forces health insurers to report drug pricing data

Managed care organizations & pharmacy benefits manager; data collection and reporting requirements.

Introduced· 2026-01-14

Who's it for

Who's it for: Everyday People

What it means for you

7/10Helps you

Good for everyday people ·

Cost shift

Plain‑English summary, cross‑checked against the official bill text.

If passed, Virginia would require insurers and pharmacy managers to publicly share detailed drug cost data and face penalties for inaccurate reports.

Our take

What we think, in plain words.

Consumers could see where drug prices come from, helping them push for lower costs, while insurers would have to spend money on audits and risk fines if they hide information.

Take action

Add your name. At 100 signatures we compile this petition and deliver it to the office — and every signer gets a message to send their own representatives.

0 of 100 in‑district signatures

Step 1 · Pick your position

Step 2 · Add your name

Picking a side above doesn't sign anything yet — a free account records your name on the petition and keeps it one signature per person. We'll bring you straight back here with your choice saved.

The facts

What the bill actually says, no spin.

The bill orders the Department of Medical Assistance Services to set standard methods for collecting drug spending data.
Managed care organizations and pharmacy benefits managers must report expenditures, rebates, and cost sources.
They must undergo an independent audit every two years and share results with the state.
The department can fine non‑compliant entities up to $10,000 or suspend their participation.